David D. McKee

10.5k total citations · 6 hit papers
24 papers, 8.9k citations indexed

About

David D. McKee is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, David D. McKee has authored 24 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Oncology. Recurrent topics in David D. McKee's work include Estrogen and related hormone effects (10 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). David D. McKee is often cited by papers focused on Estrogen and related hormone effects (10 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). David D. McKee collaborates with scholars based in United States, Netherlands and Sweden. David D. McKee's co-authors include Timothy M. Willson, Steven A. Kliewer, John T. Moore, Linda B. Moore, Stacey A. Jones, Millard H. Lambert, M. A. Watson, J�rgen Lehmann, Bryan Goodwin and Cristin M. Galardi and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David D. McKee

24 papers receiving 8.6k citations

Hit Papers

A Regulatory Cascade of the Nuclear Receptors FXR, SHP-... 1985 2026 1998 2012 2000 1998 1998 2002 2002 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David D. McKee United States 22 3.8k 3.6k 2.8k 2.7k 1.7k 24 8.9k
John T. Moore United States 34 2.8k 0.7× 3.5k 1.0× 3.4k 1.2× 3.2k 1.2× 2.0k 1.2× 68 9.1k
Derek J. Parks United States 29 3.5k 0.9× 4.4k 1.2× 1.3k 0.5× 1.8k 0.7× 1.1k 0.7× 42 9.5k
Jon L. Collins United States 41 2.9k 0.7× 5.0k 1.4× 2.1k 0.7× 1.5k 0.6× 1.6k 1.0× 71 10.4k
Linda B. Moore United States 33 4.5k 1.2× 7.2k 2.0× 3.3k 1.2× 2.9k 1.1× 2.2k 1.4× 45 13.8k
G. Bruce Wisely United States 29 1.8k 0.5× 5.9k 1.7× 1.6k 0.6× 2.0k 0.7× 1.1k 0.7× 37 10.1k
Stacey A. Jones United States 28 6.8k 1.8× 5.4k 1.5× 3.5k 1.2× 2.6k 0.9× 1.9k 1.1× 37 14.0k
Millard H. Lambert United States 41 2.2k 0.6× 8.6k 2.4× 1.6k 0.6× 3.0k 1.1× 1.7k 1.0× 58 13.4k
Charles N. Falany United States 51 1.2k 0.3× 3.4k 0.9× 2.7k 1.0× 1.6k 0.6× 1.4k 0.8× 147 7.1k
Tatsuya Sueyoshi United States 41 1.8k 0.5× 2.4k 0.7× 3.8k 1.3× 1.7k 0.6× 1.8k 1.1× 88 6.6k
Randy K. Bledsoe United States 19 2.0k 0.5× 2.5k 0.7× 893 0.3× 1.4k 0.5× 887 0.5× 23 5.3k

Countries citing papers authored by David D. McKee

Since Specialization
Citations

This map shows the geographic impact of David D. McKee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. McKee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. McKee more than expected).

Fields of papers citing papers by David D. McKee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. McKee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. McKee. The network helps show where David D. McKee may publish in the future.

Co-authorship network of co-authors of David D. McKee

This figure shows the co-authorship network connecting the top 25 collaborators of David D. McKee. A scholar is included among the top collaborators of David D. McKee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. McKee. David D. McKee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pearce, Kenneth H., Laurie K. Overton, Robert T. Gampe, et al.. (2019). BacMam production and crystal structure of nonglycosylated apo human furin at 1.89 Å resolution. Acta Crystallographica Section F Structural Biology Communications. 75(4). 239–245. 12 indexed citations
2.
Wang, Liping, William J. Zuercher, Thomas G. Consler, et al.. (2006). X-ray Crystal Structures of the Estrogen-related Receptor-γ Ligand Binding Domain in Three Functional States Reveal the Molecular Basis of Small Molecule Regulation. Journal of Biological Chemistry. 281(49). 37773–37781. 110 indexed citations
3.
Williams, Shawn P., Randy K. Bledsoe, Jon L. Collins, et al.. (2003). X-ray Crystal Structure of the Liver X Receptor β Ligand Binding Domain. Journal of Biological Chemistry. 278(29). 27138–27143. 170 indexed citations
4.
Williams, Shawn P., Randy K. Bledsoe, Jon L. Collins, et al.. (2003). Williams, S. et al. X-ray crystal structure of the liver X receptor ligand binding domain: regulation by a histidine-tryptophan switch. J. Biol. Chem. 278, 27138-27143. 26 indexed citations
5.
Xu, H. Eric, Thomas B. Stanley, Valerie G. Montana, et al.. (2002). Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature. 415(6873). 813–817. 521 indexed citations breakdown →
6.
Bledsoe, Randy K., Valerie G. Montana, Thomas B. Stanley, et al.. (2002). Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition. Cell. 110(1). 93–105. 652 indexed citations breakdown →
7.
Moore, Linda B., Jodi M. Maglich, David D. McKee, et al.. (2002). Pregnane X Receptor (PXR), Constitutive Androstane Receptor (CAR), and Benzoate X Receptor (BXR) Define Three Pharmacologically Distinct Classes of Nuclear Receptors. Molecular Endocrinology. 16(5). 977–986. 298 indexed citations
8.
Maglich, Jodi M., Ann E. Sluder, Xiaojun Guan, et al.. (2001). Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome biology. 2(8). RESEARCH0029–RESEARCH0029. 203 indexed citations
9.
Goodwin, Bryan, et al.. (2001). Regulation of the Human CYP2B6 Gene by the Nuclear Pregnane X Receptor. Molecular Pharmacology. 60(3). 427–431. 302 indexed citations
10.
Xu, H. Eric, Millard H. Lambert, Valerie G. Montana, et al.. (2001). Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences. 98(24). 13919–13924. 449 indexed citations
11.
Su, Jui‐Lan, David D. McKee, Byron Ellis, et al.. (2000). Production and Characterization of an Estrogen Receptor β Subtype-Specific Mouse Monoclonal Antibody. Hybridoma. 19(6). 481–487. 7 indexed citations
12.
Goodwin, Bryan, Stacey A. Jones, Michael A. Watson, et al.. (2000). A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis. Molecular Cell. 6(3). 517–526. 1598 indexed citations breakdown →
13.
Jones, Stacey A., Linda B. Moore, G. Bruce Wisely, et al.. (2000). The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution. Molecular Endocrinology. 14(1). 27–39. 470 indexed citations
14.
Shewchuk, Lisa M., Anne M. Hassell, Byron Ellis, et al.. (2000). Structure of the Tie2 RTK Domain. Structure. 8(11). 1105–1113. 113 indexed citations
15.
Kliewer, Steven A., John T. Moore, Jeff L. Staudinger, et al.. (1998). An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway. Cell. 92(1). 73–82. 1299 indexed citations breakdown →
16.
Lehmann, J�rgen, David D. McKee, M. A. Watson, et al.. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.. Journal of Clinical Investigation. 102(5). 1016–1023. 1314 indexed citations breakdown →
17.
Moore, John T., David D. McKee, Kimberly Slentz‐Kesler, et al.. (1998). Cloning and Characterization of Human Estrogen Receptor β Isoforms. Biochemical and Biophysical Research Communications. 247(1). 75–78. 437 indexed citations
18.
Bair, Kenneth W., et al.. (1991). 2-[(Arylmethyl)amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA binding. Journal of Medicinal Chemistry. 34(7). 1983–1990. 46 indexed citations
19.
Bair, Kenneth W., Richard L. Tuttle, V C Knick, Michael Cory, & David D. McKee. (1990). [(1-Pyrenylmethyl)amino] alcohols, a new class of antitumor DNA intercalators. Discovery and initial amine side chain structure-activity studies. Journal of Medicinal Chemistry. 33(9). 2385–2393. 70 indexed citations
20.
Cory, Michael, et al.. (1985). Design, synthesis, and DNA binding properties of bifunctional intercalators. Comparison of polymethylene and diphenyl ether chains connecting phenanthridine. Journal of the American Chemical Society. 107(8). 2528–2536. 416 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026